COVID-19: Half want boosters ASAP, but two-in-five among vaccinated say they're not sold on another shot - Angus Reid Institute
How Long Does COVID Immunity Last After a Booster Shot?
Safety Monitoring of COVID-19 mRNA Vaccine Second Booster Doses Among Adults Aged ≥50 Years — United States, March 29, 2022–July 10, 2022 | MMWR
Vaccines and Boosters: Our Best Defense Against COVID-19
Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant — United States, February 14–March 27, 2022 | MMWR
COVID-19 Vaccines and Booster Shots: Which Combination is Most Effective? - Homage Malaysia
What We Know So Far About Waning Vaccine Effectiveness - The New York Times
BNT162b2 Vaccine Booster and Mortality Due to Covid-19 | NEJM
Should I get my COVID vaccine booster? Yes, it increases protection against COVID, including Omicron
What is a booster shot and why do I need it? | OSF HealthCare
Cohort study of Covid-19 vaccine effectiveness among healthcare workers in Finland, December 2020 - October 2021 - ScienceDirect
mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar | Nature Medicine
Coronavirus (COVID-19) Update: FDA Takes Multiple Actions to Expand Use of Pfizer-BioNTech COVID-19 Vaccine | FDA
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 | MMWR
What We Know So Far About Waning Vaccine Effectiveness - The New York Times
Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60 years | Nature Medicine
Vaccines | Free Full-Text | Is Booster Dose Strategy Sufficient for Omicron Variant of SARS-CoV-2?
Effectiveness of the second COVID-19 booster against Omicron: a large-scale cohort study in Chile | Nature Communications
What We Know About Getting a Second Booster Shot of COVID-19 Vaccines | The Scientist Magazine®
Effectiveness of a third dose of BNT162b2 mRNA COVID-19 vaccine in a large US health system: A retrospective cohort study - The Lancet Regional Health – Americas
Boosters wane but showed protection against hospitalization during omicron, CDC study says - The Washington Post
Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60 years | Nature Medicine
Relative effectiveness of monovalent and bivalent mRNA boosters in preventing severe COVID-19 due to omicron BA.5 infection up to 4 months post-administration in people aged 60 years or older in Italy: a
Covid booster doses will be offered to over-40s - BBC News
Durability of Bivalent Boosters against Omicron Subvariants | NEJM
Covid booster vaccines effective against severe illness from omicron, CDC says
